- Home
- BARK vs ALDX Comparison
BARK vs ALDX Comparison
Compare BARK & ALDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BARK
- ALDX
- Stock Information
- Founded
- BARK 2011
- ALDX 2004
- Country
- BARK United States
- ALDX United States
- Employees
- BARK N/A
- ALDX N/A
- Industry
- BARK Department/Specialty Retail Stores
- ALDX Biotechnology: Pharmaceutical Preparations
- Sector
- BARK Consumer Discretionary
- ALDX Health Care
- Exchange
- BARK Nasdaq
- ALDX Nasdaq
- Market Cap
- BARK 308.9M
- ALDX 319.4M
- IPO Year
- BARK N/A
- ALDX 2014
- Fundamental
- Price
- BARK $1.89
- ALDX $5.22
- Analyst Decision
- BARK Buy
- ALDX Strong Buy
- Analyst Count
- BARK 2
- ALDX 2
- Target Price
- BARK $2.20
- ALDX $10.00
- AVG Volume (30 Days)
- BARK 1.1M
- ALDX 428.9K
- Earning Date
- BARK 02-05-2025
- ALDX 11-07-2024
- Dividend Yield
- BARK N/A
- ALDX N/A
- EPS Growth
- BARK N/A
- ALDX N/A
- EPS
- BARK N/A
- ALDX N/A
- Revenue
- BARK $488,881,000.00
- ALDX N/A
- Revenue This Year
- BARK $3.23
- ALDX N/A
- Revenue Next Year
- BARK $10.01
- ALDX N/A
- P/E Ratio
- BARK N/A
- ALDX N/A
- Revenue Growth
- BARK N/A
- ALDX N/A
- 52 Week Low
- BARK $0.74
- ALDX $2.71
- 52 Week High
- BARK $2.56
- ALDX $6.55
- Technical
- Relative Strength Index (RSI)
- BARK 45.84
- ALDX 55.82
- Support Level
- BARK $1.81
- ALDX $4.77
- Resistance Level
- BARK $1.94
- ALDX $5.24
- Average True Range (ATR)
- BARK 0.12
- ALDX 0.34
- MACD
- BARK -0.05
- ALDX 0.02
- Stochastic Oscillator
- BARK 15.69
- ALDX 70.51
About BARK BARK Inc.
BARK Inc is a vertically integrated, omnichannel brand serving dogs across two key categories: toys & accessories and consumables. It serves dogs nationwide with monthly subscription services, BarkBox and Super Chewer; e-commerce experience on BarkShop.com; custom collections via its retail partner network, including Target and Amazon; wellness products that meet dogs' needs with BARK Bright; and a personalized meal delivery service for dogs BARK Eats. The company's reportable segments are; Direct to Consumer (D2C), and Commerce. The majority of its revenue is generated from the Direct to Consumer segment which derives revenue from the sale of toys & accessories and consumables through BarkBox, Super Chewer, and the company's consumables website.
About ALDX Aldeyra Therapeutics Inc.
Aldeyra Therapeutics Inc is a biotechnology company engaged in developing and commercializing next-generation medicines to improve the lives of patients with immune-mediated diseases. The company's product candidate, reproxalap, is a first-in-class treatment in late-stage development for dry eye disease and allergic conjunctivitis. In addition, it also has additional product candidates in development for proliferative vitreoretinopathy, primary vitreoretinal lymphoma and other retinal diseases, autoimmune disease, and cancer.